. | . | Phenotypic classes . | . | . | ||
---|---|---|---|---|---|---|
Genotype . | % Defective segments . | % Dissociated . | % Incomplete . | % Absent . | ||
Single mutant | ||||||
Nrx-IV4304/TM3 | 3 (5/147) | 40 (2/5) | 0 (0/5) | 60 (3/5) | ||
Nrx-IV4304/Nrx-IV4304 | 95 (168/177) | 68 (114/168) | 23 (39/168) | 9 (15/168) | ||
wrapper175/+ | 2 (4/185) | 50 (2/4) | 50 (2/4) | 0 (0/4) | ||
wrapper175/wrapper175 | 99 (137/139) | 76 (104/137) | 24 (33/137) | 0 (0/137) | ||
Double mutant | ||||||
wrapper175/+; Nrx-IV4304/+ | 2 (1/52) | 0 (0/1) | 100 (1/1) | 0 (0/1) | ||
wrapper175/wrapper175; Nrx-IV4304/Nrx-IV4304 | 96 (71/74) | 30 (21/71) | 68 (48/71) | 3 (2/71) |
. | . | Phenotypic classes . | . | . | ||
---|---|---|---|---|---|---|
Genotype . | % Defective segments . | % Dissociated . | % Incomplete . | % Absent . | ||
Single mutant | ||||||
Nrx-IV4304/TM3 | 3 (5/147) | 40 (2/5) | 0 (0/5) | 60 (3/5) | ||
Nrx-IV4304/Nrx-IV4304 | 95 (168/177) | 68 (114/168) | 23 (39/168) | 9 (15/168) | ||
wrapper175/+ | 2 (4/185) | 50 (2/4) | 50 (2/4) | 0 (0/4) | ||
wrapper175/wrapper175 | 99 (137/139) | 76 (104/137) | 24 (33/137) | 0 (0/137) | ||
Double mutant | ||||||
wrapper175/+; Nrx-IV4304/+ | 2 (1/52) | 0 (0/1) | 100 (1/1) | 0 (0/1) | ||
wrapper175/wrapper175; Nrx-IV4304/Nrx-IV4304 | 96 (71/74) | 30 (21/71) | 68 (48/71) | 3 (2/71) |
Values in parentheses indicate the number of affected segments/total number of segments examined. For single mutants, segments A1-A7 were examined at stage 17 for defects in AMG migration using sim-Gal4 UAS-tau-GFP and anti-GFP to visualize all midline cells. AMG were identified based on morphology and position and the presence of Runt or Wrapper immunostaining. At stage 17, three phenotypes were observed: (1) Dissociated - dissociation of AMG from MP1 neurons and the failure of AMG to ensheath the PC; (2) Incomplete- dissociation coupled with a failure of AMG to ensheath the AC or PC (more severe than Dissociated alone); (3) Absent - complete absence of AMG. For double mutants, AMG were identified based on morphology, position and the presence of staining for the glial markers argos or Ect3. Homozygous Nrx-IV mutants were identified by the absence of Nrx-IV staining from the epidermis.